News Posted on February 28, 2025 BridgeBio's cancer spinout backs SPAC as path to Nasdaq – Fierce Biotech BridgeBio’s cancer spinout backs SPAC as path to Nasdaq Fierce Biotech Source: BridgeBio’s cancer spinout backs SPAC as path to Nasdaq – Fierce Biotech By sf-admin